If you need more lookups,
subscriptions start at $34 USD/month.
Jeff Jackson Location
Collegeville, PA, US
Jeff Jackson Work
Group Vice President, Translational Medicine @ (October 2023 - Present)
Vice President, Translational Sciences @ (July 2019 - March 2023)
Development Lead, Hematology @ (May 2018 - June 2019)
Early Asset Development Lead, Oncology @ (November 2013 - May 2018)
Group Director Oncology Biomarkers @ (April 2009 - November 2013)
Director of Biology @ (September 2004 - March 2009)
Asst and Assoc Director or Biology @ (January 2000 - January 2005)
Sr Investigator @ Smithkline Beecham Pharmaceuticals (January 1995 - January 2000)
Jeff Jackson Education
University of Rochester
BS (MS, PhD, Molecular Genetics; Biology)
1983-1992
Jeff Jackson Skills
Assay Development
Biomarkers
Biotechnology
Cancer
Cell
Clinical Development
Clinical Research
Clinical Trials
Drug Development
Drug Discovery
High Throughput Screening
Immunology
Lifesciences
Oncology
Pharmaceutical Industry
Pharmacology
Protein Chemistry
Translational Medicine
Translational Research
Jeff Jackson Summary
Jeff Jackson, based in Collegeville, PA, US, is currently a Group Vice President, Translational Medicine at Incyte. Jeff Jackson brings experience from previous roles at Incyte and Bristol-Myers Squibb. Jeff Jackson holds a 1983 - 1992 BS in MS, PhD, Molecular Genetics; Biology @ University of Rochester. With a robust skill set that includes Assay Development, Biomarkers, Biotechnology, Cancer, Cell and more. Jeff Jackson has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Jeff Jackson?
Find contact details for 700 million professionals.